Global Health Limited (GLH) AI Stock Analysis

• Market Cap: AU$3.98M
• Dividend Yield: N/A
• Average Volume (3M): 21.67K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.27
• Revenue Growth: -11.00%
• EPS Growth: 86.56%
• Country: AU
• Employees: 49
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.01
• Shares Outstanding: 58,574,535
• 10 Day Avg. Volume: 41,883
• 30 Day Avg. Volume: 21,670
• PEG Ratio: >-0.01
• Price to Book (P/B): -4.79
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 39 Underperform
• Price Target: AU$0.00 ▼(-100.00%Downside)

Global Health Limited's stock score reflects its significant financial challenges, including negative margins, high leverage, and unstable cash flows. The bearish technical indicators and poor valuation further support a cautious outlook. The absence of earnings call data and notable corporate events means these elements did not influence the score.

Global Health Limited Business Overview & Revenue Model

Company Description

Global Health Limited provides digital health solutions for the healthcare sector in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, post-acute care, community care, mental health services, and community rehabilitation, as well as offers software solutions for home care and aged care, consumer engagement tools, general practice, and pharmacy. The company's products include MasterCare EMR, an Electronic Medical Record; MasterCare + that helps organizations in digitizing their services and processes; MasterCare PAS, a patient administration system; PrimaryClinic, a medical and practice management software for general practitioners and specialists that share the same patient demographic. It also provides ReferralNet to send and receive various document types; LifeCard, a personal health record; and HotHealth, a digital engagement tool. In addition, the company offers MasterCare Data Warehouse that removes the need for spreadsheets, exports, and time-consuming analysis; e-switch, a middleware software to exchange data externally, internally, and between different software systems; Patient Portal, an online portal to capture patient data digitally via an online form prior to admission; and Altitude, a cloud hosting service. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.

How the Company Makes Money

Global Health Limited makes money through a diverse revenue model that encompasses multiple streams. The primary source of income is the sale of pharmaceutical products and medical devices to healthcare providers, hospitals, and clinics worldwide. Additionally, GLH generates revenue through licensing agreements and partnerships with other pharmaceutical companies, enabling the distribution and co-development of new treatments. The company also offers health technology services, such as electronic health record systems and telemedicine platforms, which provide recurring revenue through subscription fees and service contracts. Strategic collaborations with research institutions and government agencies further bolster GLH's earnings by securing funding and facilitating access to new markets.

Global Health Limited Financial Statement Overview

Summary

Global Health Limited faces significant financial challenges, including negative margins, negative equity, and unstable cash flows. Despite revenue growth, the company's profitability and financial stability are severely compromised.

Income Statement

Global Health Limited has shown a consistent increase in revenue over the years, with a revenue growth rate of 3.90% from 2023 to 2024. However, the company has been struggling with negative margins, including a net profit margin of -16.15% and a gross profit margin of -8.49% in 2024. The EBIT and EBITDA have also remained negative, indicating operational challenges. Despite revenue growth, profitability remains a significant concern.

Balance Sheet

The balance sheet reveals financial instability with a negative stockholders' equity of -2,900,009 in 2024, indicating more liabilities than assets. The debt-to-equity ratio cannot be calculated due to negative equity, posing a high financial risk. The equity ratio is also negative, reflecting the company's financial distress. Overall, the company exhibits financial vulnerability and high leverage.

Cash Flow

Cash flow analysis shows a volatile cash flow situation with negative free cash flow and operating cash flow in 2024. The free cash flow to net income ratio is concerning, indicating the company struggles to generate cash flow relative to its net income losses. Despite some financing cash inflows, the overall cash flow position remains weak.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	8.42M	8.66M	7.82M	6.54M	7.03M	5.97M
Gross Profit	887.00K	2.00M	-2.18M	-664.00K	812.71K	626.90K
EBITDA	-1.17M	-1.22M	-7.14M	-1.69M	57.05K	472.96K
Net Income	-868.00K	-1.31M	-8.05M	-2.05M	-488.00K	-200.00K
Balance Sheet
Total Assets	2.14M	3.08M	3.12M	11.03M	9.04M	6.62M
Cash, Cash Equivalents and Short-Term Investments	1.81M	2.07M	2.24M	6.38M	4.84M	666.28K
Total Debt	1.36M	1.03M	44.94K	141.83K	304.11K	816.41K
Total Liabilities	5.66M	5.98M	4.74M	4.95M	5.00M	5.47M
Stockholders Equity	-3.52M	-2.90M	-1.62M	6.09M	4.04M	1.15M
Cash Flow
Free Cash Flow	-401.93K	-1.15M	-4.36M	-2.08M	675.18K	-839.90K
Operating Cash Flow	-384.44K	-1.13M	-3.46M	-1.18M	1.37M	-141.04K
Investing Cash Flow	-12.48K	-17.48K	-902.77K	-778.93K	-428.74K	-252.78K
Financing Cash Flow	813.53K	982.56K	240.86K	3.50M	3.23M	256.10K

Global Health Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.08
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GLH, the sentiment is Neutral. The current price of 0.08 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.08, and below the 200-day MA of 0.12, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 61.91 is Neutral, neither overbought nor oversold. The STOCH value of 114.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:GLH.

Global Health Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	52 Neutral	$7.50B	0.31	-61.87%	2.27%	17.10%	1.59%
GLH	39 Underperform	AU$3.98M	―		―	-11.00%	86.56%
UV7		€2.28M	―	-23.39%	―	―	―
EMD	44 Neutral	AU$16.51M	―	-74.80%	―	-9.16%	89.23%
HIQ	39 Underperform	AU$6.90M	―		―	18.53%	33.17%
OPL	35 Underperform	AU$6.81M	―		―	-67.78%	37.66%
ICR	34 Underperform	AU$3.42M	―	-309.52%	―	73.53%	-7.35%

Global Health Limited Corporate Events

Global Health Limited Partners to Enhance Indigenous Maternal Care

Global Health Limited has announced a new contract to support ‘Baby Coming You Ready?’, a culturally safe digital platform aimed at improving antenatal and postnatal care for Aboriginal and Torres Strait Islander families. This initiative will deploy Global Health’s HotHealth and ReferralNet platforms across 21 health organizations over the next two years, enhancing communication and care planning for Indigenous families. The project aligns with national priorities to close the health disparity gap, particularly during the first 2,000 days of a child’s life, and underscores Global Health’s commitment to culturally responsive healthcare solutions.

Global Health Limited Partners with Very Special Kids to Enhance Paediatric Palliative Care

Global Health Limited has secured a three-year contract with Very Special Kids to implement its MasterCare Plus Client Management System, tailored for paediatric palliative care. This deployment will enhance digital healthcare operations, streamline service delivery, and improve clinician-family engagement through its SaaS solutions, including secure messaging and digital front door platforms. The agreement, with options for extension, is expected to strengthen Global Health’s position in the healthcare technology sector and support Very Special Kids’ comprehensive care services.

Global Health Limited Navigates Financial Challenges and Expands SaaS Offerings

Global Health Limited reported a $750K loss in income due to the end of a contract with SA Health, impacting its cash flow for the March 2025 quarter. However, the company anticipates that new sales will compensate for this loss over the next year. The company is transitioning to a SaaS business model, which is expected to reduce costs and increase margins. Investments in research and development have decreased, aligning with industry standards as products reach market readiness. Global Health is also expanding its MasterCare Plus platform and other digital solutions to new market segments, despite challenges in the Australian public healthcare sector due to funding constraints and increased demand.